#USA #New York #ASCO #Elsevier #ClinicalPath

Elsevier's ClinicalPath Recognized as a Quality Solution for the ASCO Certified Program

Elsevier has recently announced that its oncology decision support tool, ClinicalPath, has received the designation of Recognized Quality Solution (RQS) from the Association for Clinical Oncology (ASCO). This milestone highlights ClinicalPath's commitment to enhancing patient-centered cancer care and aligning with the ASCO Certified program’s standards.

Omry Bigger, the President of Clinical Solutions at Elsevier, emphasized the importance of this recognition, stating, "Cancer practices want to deliver the best care possible, and this recognition means they can be even more confident in the value ClinicalPath provides." The RQS designation not only confirms that ClinicalPath meets ASCO's rigorous testing standards but also reinforces its ability to assist cancer centers in achieving their reporting and compliance goals.

Clifford A. Hudis, MD, FACP, FASCO, the CEO of ASCO, supported this initiative, noting, "We are pleased to designate Elsevier's ClinicalPath as a Recognized Quality Solution. ClinicalPath underwent a rigorous validation process that reviewed the necessary data elements for clinical quality measurement and pathway utilization. This recognition demonstrates Elsevier's commitment to assisting practices with meeting certification requirements."

Importance of ClinicalPath in Oncology

With ClinicalPath, oncology practices can ensure they offer consistent high-quality care that adheres to ASCO Certified guidelines. Some of the primary advantages include:

• - Evidence-Based Pathways: ClinicalPath leverages thorough research and constantly updated content, which integrates clinical trials to provide solid evidence-based pathways for cancer treatment.
• - Streamlined Reporting: The solution facilitates easy quality reporting and compliance through its automated system that captures pathway utilization, ensuring that practices maintain high standards with lesser administrative burden.
• - Support for Value-Based Models: By enhancing credibility among payers, ClinicalPath assists cancer centers in aligning with value-based care models, which is crucial in today's healthcare landscape.

About ASCO Certified Program

The ASCO Certified program focuses on oncology patient-centered care, rooted in the Oncology Medical Home (OMH) Standards established by the American Society of Clinical Oncology and the Community Oncology Alliance (COA). These standards ensure patient care is holistic and meets the higher benchmarks necessary for effective treatment.

ASCO's certification aims to reach a comprehensive consensus on what cancer patients should expect from their care teams, thereby supporting better outcomes and experiences.

Acknowledging Elsevier’s Role

Since its inception over a century ago, Elsevier has positioned itself as a leading contributor to advancing healthcare through innovative information solutions and scholarly communications. The company's role in evolving ClinicalPath reflects a dedication to facilitating research and empowering healthcare professionals worldwide.

As a part of the global landscape, Elsevier remains committed to not only enhancing healthcare outcomes but also emphasizing principles of inclusion and sustainability across its operations. The Elsevier Foundation plays a crucial role by supporting international research collaborations and healthcare partnerships.

In conclusion, the recognition of ClinicalPath as an RQS by ASCO sets a precedent for the continual improvement of patient care within oncology, demonstrating that quality solutions can significantly impact the standards practiced in cancer treatment. As such, cancer centers can look forward to improved methodologies and enhanced patient experiences bolstered by this collaboration. For more information on ClinicalPath and its benefits, interested parties can visit Elsevier’s website or reach out directly via their communication channels.